Il-8 receptor antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/27 (2006.01) A61K 31/17 (2006.01)

Patent

CA 2377341

This invention provides for a method of treating a chemokine mediated disease, wherein the chemokine is one which binds to an IL-8 .alpha. or .beta. receptor and which method comprises administering an effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. In particular the chemokine is IL-8.

L'invention concerne une méthode de traitement d'une maladie médiée par la chimiokine, la chimiokine étant d'un type qui se lie à un récepteur .alpha. ou .beta. de l'IL-8. Cette méthode consiste à administrer une dose efficace d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable dudit composé. La chimiokine est notamment l'IL-8.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Il-8 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Il-8 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Il-8 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2002370

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.